The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Open-label, single-arm, single-center phase 1b/2 clinical study of fruquintinib combined with trastuzumab and XELOX in the first-line treatment of advanced HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma.
 
Huifang Lv
No Relationships to Disclose
 
Yunduan He
No Relationships to Disclose
 
Caiyun Nie
No Relationships to Disclose
 
Beibei Chen
No Relationships to Disclose
 
Weifeng Xu
No Relationships to Disclose
 
Jianzheng Wang
No Relationships to Disclose
 
Jing Zhao
No Relationships to Disclose
 
Xiaobing Chen
No Relationships to Disclose